Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Solid Biosciences Inc.
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 1, 2026
Solid Biosciences to Participate at Upcoming Investor Conferences
June 1, 2026
Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates
May 29, 2026
Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy
May 28, 2026
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 28, 2026
Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy
May 27, 2026
Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy
May 27, 2026
Solid Biosciences to Participate at Upcoming Investor Conferences
May 24, 2026
Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock
May 22, 2026
Solid Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
May 21, 2026
1
2
3
Next Page
→